We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO International ConventionJune 3-6, 2019
BIO World Congress on Industrial Biotechnology and Ag TechJuly 8-11, 2019
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
February 11 - 12, 2019 | New York, New York
Sara Michelmore is Senior Vice President, Investor Relations at MacDougall. Sara joined the agency in 2018 to oversee the Investor Relations practice, where she utilizes her extensive Wall Street and consulting experience, insights and relationships to advise clients on the strategic positioning and communication of their science and technology to the investment community. She enjoys helping companies increase their visibility and credibility to the Street and strategically navigate evolving capital needs and maximize valuation in the context of ever changing market dynamics. Past experience includes 25 years in the Health Care industry in various roles. She spent 15 years working as a Wall Street Sell Side Analyst, including 12 years at Cowen and Company, where she established strong relationships with both private and public investors. Her background also includes over 5 years in Healthcare management consulting and advisory, focused on market assessment, forecasting, valuation analysis, investor position and outreach. Most recently she served as a Client Leader & Executive of Human Care Systems, a fast growing HCIT company focused on solutions for Therapy Management & Adherence. Sara graduated from Bowdoin College with a bachelor's degree in Biochemistry, and minor in Economics.
This speaker's sessions: